⌘K

Login Start Free

Home/Filings/4/0001181431-13-002495

4//SEC Filing

OCLASSEN GLENN A 4

Accession 0001181431-13-002495

CIK 0001178711other

View on SEC.gov Company Profile

Filed

Jan 7, 7:00 PM ET

Accepted

Jan 8, 7:01 PM ET

Size

9.9 KB

Accession

0001181431-13-002495

Insider Transaction Report

Form 4

Period: 2013-01-07

Transcept Pharmaceuticals IncTSPT

OCLASSEN GLENN A

DirectorPresident and CEO

Transactions

Award
Common Stock Option (right to buy)
2013-01-07+250,000→ 250,000 total
Exercise: $5.40Exp: 2023-01-07→ Common Stock (250,000 underlying)

Footnotes (1)

[F1]The option vests in forty-eight equal monthly installments beginning on February 7, 2013.

Documents

2 files

Issuer

Transcept Pharmaceuticals Inc

CIK 0001178711

Entity typeother

Related Parties

1

filerCIK 0001210529

Filing Metadata

Form type: 4
Filed: Jan 7, 7:00 PM ET
Accepted: Jan 8, 7:01 PM ET
Size: 9.9 KB

View on SEC.gov